|

mFOLFOX7+Camrelizumab+Apatinib Clinical Trials

1 actively recruiting trial

Also known as: Combination Product: Systemic chemotherapy combined with Apatinib and Camrelizumab

Pipeline

Phase 2: 1

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Indications

  • Liver Disease1
  • Stage III Hepatocellular Cancer (CNLC Staging)1
  • Liver Cancer1
  • Cancer1

Other1 trial

mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.